Skip to main content

Advertisement

SpringerLink
Log in

Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer’s disease

  • Original Article
  • Published:
GeroScience Aims and scope Submit manuscript

Abstract

Young-onset and late-onset Alzheimer’s disease has different clinical presentations with late-onset presenting most often with memory deficits while young-onset often presents with a non-amnestic syndrome. However, it is unknown whether there are differences in presentation and progression of neuropsychiatric symptoms in young- versus late-onset Alzheimer’s disease. We aimed to investigate differences in the prevalence and severity of neuropsychiatric symptoms in patients with young- and late-onset Alzheimer’s disease longitudinally with and without accounting for the effect of medication usage. Sex differences were also considered in these patient groups. We included 126 young-onset and 505 late-onset Alzheimer’s disease patients from National Alzheimer’s Coordinating Center–Uniform Data Set (NACC-UDS) and Alzheimer’s Disease Neuroimaging Initiative (ADNI). We investigated the prevalence and severity of neuropsychiatric symptoms using the Neuropsychiatric Inventory–Questionnaire over 4 visits with 1-year intervals, using a linear mixed-effects model. The prevalence of depression was significantly higher in young-onset than late-onset Alzheimer’s disease over a 4-year interval when antidepressant usage was included in our analyses. Our findings suggest that neuropsychiatric symptom profiles of young- and late-onset Alzheimer’s disease differ cross-sectionally but also display significant differences in progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data is available at National Alzheimer’s Coordinating Center–Uniform Data Set (NACC-UDS) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) databases.

References

  1. Global action plan on the public health response to dementia 2017–2025. Geneva: World Health Organization; 2017.

  2. Scheltens P, Blennow K, Breteler MMB, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer’s disease. Lancet. 2016;388(10043):505–17.

    Article  CAS  PubMed  Google Scholar 

  3. Eriksson H, Fereshtehnejad S-M, Falahati F, Farahmand B, Religa D, Eriksdotter M. Differences in routine clinical practice between early and late onset Alzheimer’s disease: data from the Swedish Dementia Registry (SveDem). J Alzheimers Dis JAD. 2014;41(2):411–9.

    Article  CAS  PubMed  Google Scholar 

  4. Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study. J Neurol Neurosurg Psychiatry. 2005;76(1):112–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sakai M, Hanyu H, Kume K, Sato T, Hirao K, Kanetaka H, et al. Rate of progression of Alzheimer’s disease in younger versus older patients: a longitudinal single photon emission computed tomography study. Geriatr Gerontol Int. 2013;13(3):555–62.

    Article  PubMed  Google Scholar 

  6. Nochlin D, van Belle G, Bird TD, Sumi SM. Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1993;7(4):212–22.

    CAS  PubMed  Google Scholar 

  7. Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer’s disease: a CERAD analysis, Part XII. Neurology. 1996;46(1):136–41.

    Article  CAS  PubMed  Google Scholar 

  8. Seltzer B, Sherwin I. A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two? Arch Neurol. 1983;40(3):143–6.

    Article  CAS  PubMed  Google Scholar 

  9. Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, et al. Age at onset of Alzheimer’s disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology. 1994;44(7):1215–20.

    Article  CAS  PubMed  Google Scholar 

  10. Katzman R. Alzheimer’s disease as an age-dependent disorder. CIBA Found Symp. 1988;134:69–85.

    CAS  PubMed  Google Scholar 

  11. Bowler JV, Munoz DG, Merskey H, Hachinski V. Factors affecting the age of onset and rate of progression of Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 1998;65(2):184–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Panegyres PK, Chen H-Y. Differences between early and late onset Alzheimer’s disease. Am J Neurodegener Dis. 2013;2(4):300–6.

    PubMed  PubMed Central  Google Scholar 

  13. Toyota Y, Ikeda M, Shinagawa S, Matsumoto T, Matsumoto N, Hokoishi K, et al. Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22(9):896–901.

    Article  PubMed  Google Scholar 

  14. Ferran J, Wilson K, Doran M, Ghadiali E, Johnson F, Cooper P, et al. The early onset dementias: a study of clinical characteristics and service use. Int J Geriatr Psychiatry. 1996;11(10):863–9.

    Article  Google Scholar 

  15. Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, et al. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer’s Disease Consortium (EADC) study. Acta Clin Belg. 2007;62(6):426–32.

    Article  CAS  PubMed  Google Scholar 

  16. Smits LL, Pijnenburg YAL, Koedam ELGE, van der Vlies AE, Reuling IEW, Koene T, et al. Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile. J Alzheimers Dis JAD. 2012;30(1):101–8.

    Article  PubMed  Google Scholar 

  17. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288(12):1475–83.

    Article  PubMed  Google Scholar 

  18. Kiely KM, Mortby ME, Anstey KJ. Differential associations between sensory loss and neuropsychiatric symptoms in adults with and without a neurocognitive disorder. Int Psychogeriatr. 2018;30(2):261–72.

    Article  PubMed  Google Scholar 

  19. Cuijpers P. Depressive disorders in caregivers of dementia patients: a systematic review. Aging Ment Health. 2005;9(4):325–30.

    Article  CAS  PubMed  Google Scholar 

  20. de Vugt ME, Nicolson NA, Aalten P, Lousberg R, Jolle J, Verhey FRJ. Behavioral problems in dementia patients and salivary cortisol patterns in caregivers. J Neuropsychiatry Clin Neurosci. 2005;17(2):201–7.

    Article  PubMed  Google Scholar 

  21. Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, et al. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry. 2015;172(5):460–5.

    Article  PubMed  PubMed Central  Google Scholar 

  22. González-Salvador MT, Arango C, Lyketsos CG, Barba AC. The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry. 1999;14(9):701–10.

    Article  PubMed  Google Scholar 

  23. Chiao C-Y, Wu H-S, Hsiao C-Y. Caregiver burden for informal caregivers of patients with dementia: a systematic review. Int Nurs Rev. 2015;62(3):340–50.

    Article  PubMed  Google Scholar 

  24. Bature F, Guinn B, Pang D, Pappas Y. Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016. BMJ Open. 2017;7(8):e015746.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease; rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(2):126–33.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Reed J, Cantley C, Clarke CL, Stanley D. Services for younger people with dementia: problems with differentiating needs on the basis of age. Dementia. 2002;1(1):95–112.

    Article  Google Scholar 

  27. Rosness TA, Barca ML, Engedal K. Occurrence of depression and its correlates in early onset dementia patients. Int J Geriatr Psychiatry. 2010;25(7):704–11.

    Article  PubMed  Google Scholar 

  28. van Vliet D, de Vugt ME, Aalten P, Bakker C, Pijnenburg YAL, Vernooij-Dassen MJFJ, et al. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer’s disease - part 1: findings of the two-year longitudinal NeedYD-study. Dement Geriatr Cogn Disord. 2012;34(5–6):319–27.

    Article  PubMed  Google Scholar 

  29. Porter VR, Buxton WG, Fairbanks LA, Strickland T, O’Connor SM, Rosenberg-Thompson S, et al. Frequency and characteristics of anxiety among patients with Alzheimer’s disease and related dementias. J Neuropsychiatry Clin Neurosci. 2003;15(2):180–6.

    Article  PubMed  Google Scholar 

  30. Lawlor BA, Ryan TM, Schmeidler J, Mohs RC, Davis KL. Clinical symptoms associated with age at onset in Alzheimer’s disease. Am J Psychiatry. 1994;151(11):1646–9.

    Article  CAS  PubMed  Google Scholar 

  31. Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, et al. Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set. Alzheimer Dis Assoc Disord. 2018;32(4):351–8.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–14.

    Article  CAS  PubMed  Google Scholar 

  33. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–4.

    Article  CAS  PubMed  Google Scholar 

  34. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2018. Available from: https://www.R-project.org/

  35. Makowski D. The psycho package: an efficient and publishing-oriented workflow for psychological science. J Open Source Softw. 2018;3(22):470.

    Article  Google Scholar 

  36. Kaiser NC, Liang L-J, Melrose RJ, Wilkins SS, Sultzer DL, Mendez MF. Differences in anxiety among patients with early- versus late-onset Alzheimer’s disease. J Neuropsychiatry Clin Neurosci. 2014;26(1):73–80.

    Article  PubMed  Google Scholar 

  37. Panegyres PK, Chen HY. Early-onset Alzheimer’s disease: a global cross-sectional analysis. Eur J Neurol. 2014;21(9):1149–e65.

    Article  CAS  PubMed  Google Scholar 

  38. Zhao Q-F, Tan L, Wang H-F, Jiang T, Tan M-S, Tan L, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264–71.

    Article  PubMed  Google Scholar 

  39. Ferreira M d C, Abreu MJ, Machado C, Santos B, Machado Á, Costa AS. Neuropsychiatric profile in early versus late onset Alzheimer’s disease. Am J Alzheimers Dis Other Dement. 2018;33(2):93–9.

    Article  Google Scholar 

  40. Hori K, Oda T, Asaoka T, Yoshida M, Watanabe S, Oyamada R, et al. First episodes of behavioral symptoms in Alzheimer’s disease patients at age 90 and over, and early-onset Alzheimer’s disease: comparison with senile dementia of Alzheimer’s type. Psychiatry Clin Neurosci. 2005;59(6):730–5.

    Article  PubMed  Google Scholar 

  41. Svanberg E, Spector A, Stott J. The impact of young onset dementia on the family: a literature review. Int Psychogeriatr. 2011;23(3):356–71.

    Article  PubMed  Google Scholar 

  42. Mendez MF. Early-onset Alzheimer’s disease: nonamnestic subtypes and type 2 AD. Arch Med Res. 2012;43(8):677–85.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Calleo J, Kunik ME, Reid D, Kraus-Schuman C, Paukert A, Regev T, et al. Characteristics of generalized anxiety disorder in patients with dementia. Am J Alzheimers Dis Other Dement. 2011;26(6):492–7.

    Article  Google Scholar 

  44. Kuruppu DK, Matthews BR. Young-Onset Dementia. Semin Neurol. 2013;33(4):365–85.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.

Funding

This work was supported by Toronto Western & General Foundation. The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P30 AG062428-01 (PI James Leverenz, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P30 AG062421-01 (PI Bradley Hyman, MD, PhD), P30 AG062422-01 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI Robert Vassar, PhD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P30 AG062429-01(PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P30 AG062715-01 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD). Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada.

Author information

Authors and Affiliations

  1. Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King’s College Circle, Toronto, ON, M5S 1A8, Canada

    Melisa Gumus & Maria Carmela Tartaglia

  2. Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Ave., Toronto, ON, M5T 2S8, Canada

    Melisa Gumus, Namita Multani & Maria Carmela Tartaglia

  3. Department of Psychology, Faculty of Arts and Science, University of Toronto, Sidney Smith Hall, 100 St. George Street, Toronto, ON, M5S 3G3, Canada

    Michael L. Mack

  4. Division of Neurology, Toronto Western Hospital, University Health Network, 399 Bathurst St., Toronto, ON, M5T 2S8, Canada

    Maria Carmela Tartaglia

Authors
  1. Melisa Gumus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Namita Multani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael L. Mack
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Carmela Tartaglia
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the Alzheimer’s Disease Neuroimaging Initiative

Contributions

M.G. analyzed, interpreted the data, and wrote the first draft of the manuscript. N.M. obtained the data from the databases and selected participants. M.L.M. assisted with the analysis and the model. M.C.T. provided advice throughout the process and supervised the project.

Corresponding author

Correspondence to Maria Carmela Tartaglia.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval and consent to participate

Ethics approval and consent were obtained at the site by National Alzheimer’s Coordinating Center–Uniform Data Set (NACC-UDS) and Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.

Supplementary information

ESM 1

(DOCX 552 kb)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gumus, M., Multani, N., Mack, M.L. et al. Progression of neuropsychiatric symptoms in young-onset versus late-onset Alzheimer’s disease. GeroScience 43, 213–223 (2021). https://doi.org/10.1007/s11357-020-00304-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11357-020-00304-y

Keywords

Search

Navigation